Background: Alcoholics are at heightened risk for developing active tuberculosis. This study evaluates chronic alcohol consumption in a murine model of vaccination with Mycobacterium bovis Bacille Calmette-Gue`rin (BCG) and subsequent pulmonary infection with virulent Mycobacterium tuberculosis.
M
YCOBACTERIUM TUBERCULOSIS, THE etiologic agent of tuberculosis (TB), currently infects one-third of the world's population, with a rising incidence rate (0.4% ⁄ y) (World Health Organization, 2010) . The vast majority of the TB-infected population has latent infection, in which the host's antimycobacterial cell-mediated immunity (previously established at the inception of infection) maintains the infection in a state of chronic persistence. During latent infection, viable organisms are present in relatively low burden, but those organisms fail to progressively replicate, because of effective adaptive Th1 immunity. During this postinfectious latent period, the infection may ''reactivate,'' with the development of active progressive disease (Wayne and Sohaskey, 2001 ). This progression occurs annually in 8 million people globally (approximately 10% of those infected), and 2 million of those die of the disease (World Health Organization, 2010) . Many questions remain unanswered regarding the mechanism(s) of the shift from the latent infection to active TB, but numerous factors are thought to be associated with the breakdown of the latent state and the conversion to active disease, including age, immunosuppressive conditions (e.g., chronic corticosteroid use, human immunodeficiency virus infection, organ transplantation), diabetes mellitus, renal failure, silicosis, postgastrectomy state, and injection drug use (ATS ⁄ CDC, 2000) .
Effective vaccination against M. tuberculosis remains a challenge. For decades, many countries have administered a live vaccine of the attenuated strain, Mycobacterium bovis Bacille Calmette-Gue´rin (BCG) to children, but protection from this vaccine is suboptimal. It confers protection against disseminated M. tuberculosis at younger ages (especially meningitis), but fails to protect against adult infection or reactivation disease (Flynn, 2004) . In murine models, BCG vaccination confers partial protection against virulent M. tuberculosis, and is used as a model for the development of adaptive immunity, as well as a benchmark for experimental candidate vaccines (Goonetilleke et al., 2003; Grode et al., 2005; Hinchey et al., 2007; Mason et al., 2001) .
Alcohol consumption has been identified as a risk factor for active tuberculosis (Borgdorff et al., 1998; Buskin et al., 1994; Friedman et al., 1987; Hudolin, 1975; Kline et al., 1995) . Owing to the confounding host and ⁄ or lifestyle factors that factor into alcohol consumption, it has been difficult to discern the specific contribution of alcohol to active TB in human studies. In a murine model, alcohol disrupts the containment of a pulmonary challenge with the virulent strain M. tuberculosis H37Rv (Mason et al., 2004) . Vaccination of mice with M. bovis BCG, via generation of adaptive antimycobacterial immunity, affords partial protection against a subsequent challenge with M. tuberculosis H37Rv (Mason et al., 2001) . We examined the effects of 2 regimens of chronic alcohol feeding in a murine model utilizing vaccination with BCG prior to pulmonary challenge with M. tuberculosis H37Rv. We found that varying the timing of alcohol feeding in relation to BCG vaccination differentially impacts the development of BCG immunity, and also the outcome from a subsequent lung infection with M. tuberculosis. These findings may, in part, explain the heightened propensity for alcoholics to develop active disease after infection with M. tuberculosis. They also may have broader relevance for the role of alcohol in vaccine efficacy.
MATERIALS AND METHODS

Animals
Specific pathogen-free BALB ⁄ c mice (NCI Animal Program, Frederick, MD) were used for these experiments. Animals were housed in the LSUHSC Biocontainment Level-3 Laboratory and experiments were performed in the Biocontainment Level-3 Laboratory in accordance with appropriate safety precautions recommended by the CDC (Department of Health and Human Services, 2009). All animal procedures were approved by the LSUHSC Institutional Animal Care and Use Committee and the LSUHSC Institutional Biosafety Committee. All data at day 14 and beyond represent groups of n ‡ 4 unless otherwise stated, and the results shown are representative experiments that were reproduced in replicate experiments.
Chronic Alcohol Diet
Mice consumed the Lieber-DeCarli liquid ethanol diet containing 36% ethanol liquid ethanol diet (LED Group) (#710260; Dyets, Inc., Bethlehem, PA), or were pair-fed an isocaloric liquid control diet (LCD Group) (#710027; Dyets, Inc.). Animals were fed with their respective liquid diet for 5 of 7 days and given chow ad libitum for 2 of 7 days. Alcohol-consuming animals were given water containing 20% (w ⁄ v) ethanol on the 2 chow days. This dietary regimen was begun either 3 weeks before or 3 weeks after vaccination with M. bovis BCG, and was continued until the end of the experiment. Serum alcohol concentrations (random morning sample) were measured. Twenty-one days after either BCG vaccination (in the LED ⁄ BCG group) or alcohol diet initiation (3 weeks following BCG vaccination in the BCG ⁄ LED group), mice were challenged with M. tuberculosis H37Rv.
Vaccination with M. bovis BCG M. bovis BCG was obtained from ATCC (Rockville, MD, catalog #35734). All mice were administered BCG subcutaneously (4 · 10 5 cfu) in the left hind footpad either 3 weeks prior (BCG ⁄ LED group) or subsequent to the initiation of the alcohol diet (LED ⁄ BCG group), which in both situations was a minimum of 3 weeks prior to pulmonary inoculation with M. tuberculosis H37Rv (Baldwin et al., 1998) .
M. tuberculosis H37Rv Infection
M. tuberculosis H37Rv (Colorado State University School of Veterinary Medicine #UN2814, Fort Collins, CO) was prepared and inoculated into mice intratracheally (50 to 100 cfu) as previously described (Mason et al., 2004) . At serial time points (Days 7, 14, 21 , and 28) after inoculation, mice were sacrificed and lungs were quantitatively cultured. M. tuberculosis organism burden was then compared between the LED and LCD groups.
Isolation of Lung and Lung-Associated Lymph Node Lymphocytes
Lung and lung-associated lymph node (LALN) lymphocytes were isolated as previously described (Mason et al., 2004) . CD4 + lymphocytes were positively selected from total lung cells and LALN cells with magnetic beads (Invitrogen Corp., Carlsbad, CA) (Anderson et al., 1993; Collins et al., 1996; Mason et al., 2001 ). CD4
+ lymphocytes isolated by the magnetic bead technique were >95% pure for the LALN and lung populations when assayed by flow cytometry (data not shown).
CD4 + Lymphocyte Cytokine Production
Cytokine elicitation from CD4 + lymphocytes was performed in vitro with M. tuberculosis-infected peritoneal macrophages (PMs) as previously described (Mason et al., 2004) . Briefly, PMs were obtained by peritoneal lavage after elicitation with concanavalin A 96 hours previously. PMs were plated at 2 · 10 5 cells ⁄ well, allowed to adhere, infected with M. tuberculosis H37rv (multiplicity of infection [MOI] 5:1) overnight, and incubated in culture for 24 hours. After this time, LALN or lung CD4 + T cells (1 · 10 5 ⁄ well) were added to the wells for 48 hours. Control wells were included.
After the in vitro incubation, supernatants were saved at )80°C and subsequently assayed for interferon (IFN)-c and interleukin (IL) 10 by ELISA (R&D Systems, Minneapolis, MN). The lower limits of detection for these assays were IFN-c: 2 pg ⁄ ml; and IL-10: 4 pg ⁄ ml. Cytokine levels were then compared between the LED and LCD groups.
Isolation of Popliteal Lymph Node Cells and IFN-c ELISpot Assay
Three weeks after BCG vaccination and alcohol feeding (BCG ⁄ LED and LED ⁄ BCG groups), mice were sacrificed and the left hind leg popliteal lymph nodes (PLNs) were dissected, removed, and dispersed into single cell suspensions. Cells were plated in 96-well murine IFN-c ELISpot plates (R&D Systems) at 1 · 10 6 cells ⁄ well and stimulated with purified protein derivative (PPD) 5 ug ⁄ ml (Mycos Research, Loveland, CO) for 48 hours in a 37°C ⁄ 5%CO 2 incubator. Control wells contained cells in media that were not stimulated. After incubation, wells were washed 3 times with ELISpot wash buffer and 1 time with cold deionized water to lyse any remaining cells. Detection antibody was added for 4 hours followed by streptavidin-AP for 2 hours, and then 5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium (BCIP ⁄ NBT) Chromogen was added for 1 hour to develop spots. The numbers of spots were enumerated and compared between the groups. In 1 assay, CD8 + T cells were positively selected and removed from the PLN cells using magnetic beads (Invitrogen), enriching the resulting PLN cells for CD4 + T cells (in order to exclude CD8 + T cells as the major source of IFN-c). Spot numbers were then compared between the groups.
Statistical Analysis
Differences between BCG ⁄ LED and LED ⁄ BCG groups were analyzed by ANOVA, with a Bonferroni Dunn follow-up test. A p-value of £0.05 was considered significant (Bourke et al., 1985) .
RESULTS
Chronic Alcohol Diet
Animals on the LED diet consumed 8 ml⁄ liquid diet ⁄ d and gained weight throughout the course of the experiments, though slightly more slowly than the mice on the LCD. Based on dietary consumption, the caloric intake of our mice was 8 to 9 kcal ⁄ d, which is at the lower end of the normal range for adult BALB ⁄ c mice (Subcommittee on Laboratory Animal Nutrition, Committee on Animal Nutrition, Board on Agriculture, and National Research Council, 1995). Serum alcohol levels (random morning sample obtained immediately after the 12-hour dark cycle ended) were measured by the LSUHSC Alcohol Research Center Core Laboratory with an AM1 Alcohol Analyzer (Analox Instruments, Lunenburg, MA) on representative mice (n = 15) on the LED diet for 4 to 6 weeks, with a median concentration of 39 mg ⁄ dl (range 19 to 130 mg ⁄ dl). Serum albumin levels were also assayed at the sacrifice time points (after 5 to 9 weeks of alcohol or control diet administration), and all mean values of both the LED and LCD groups fell within or slightly above the reference range for mice (2.5 to 3.0 gm ⁄ dl) (Research Animal Resources, 2004) .
Alcohol Consumption Effects on BCG-Induced Protection Against M. tuberculosis
Vaccination with BCG prior to intratracheal inoculation with M. tuberculosis confers significant protection ( ‡1 logfold) against growth of M. tuberculosis in the lung, as previously reported (Mason et al., 2001 ), but alcohol consumption prior to vaccination significantly impairs BCG-induced protection in the LED⁄ BCG mice at 21 and 28 days after M. tuberculosis inoculation (Fig. 1A) , with 2-to 3-fold higher organism burdens at those times. The challenge was performed in triplicate, confirming an alcohol-induced M. tuberculosis growth disparity in the lung with consistently significantly higher organism burden (replicate data not shown). However, when BCG vaccination was administered 3 weeks prior to the initiation of alcohol feeding (BCG ⁄ LED) (and M. tuberculosis was inoculated 3 weeks after beginning the alcohol diet), culture results revealed similar control of M. tuberculosis in the lungs of the alcohol and control diet mice over the same time course (Fig. 1B) . Thus, in order for alcohol to adversely impact BCG-induced protection, alcohol consumption had to be ongoing at the time the vaccine was administered. If alcohol was begun after vaccination, it failed to alter BCG-induced protection against M. tuberculosis.
CD4 + Lymphocyte Cytokine Production
At the serial time points at which the lungs were cultured for M. tuberculosis burden, as well as at the Day 35 time point, lung and LALN were harvested and CD4 + lymphocytes isolated as previously described. CD4 + lymphocytes isolated from LALN and lung from both the LED ⁄ BCG and BCG ⁄ LED groups were assayed for elicited cytokine production after stimulation by M. tuberculosis-infected PMs as described above. Figure 2A ,B show elicited IFN-c production from both the sites by LED ⁄ BCG and (Fig. 2B) , corresponding to the time frame when there is discrepancy in bacterial growth between the groups (see Fig. 1 ). However, in the BCG ⁄ LED group (Fig. 2C,D) , there was no decrement in IFN-c production by the CD4 + LALN or lung T cells compared with the BCG ⁄ LCD group. In fact, there was heightened IFN-c production by the CD4 + T cells from both sites in the BCG ⁄ LED group. Thus, IFN-c production, elicited in vitro from equal numbers of LALN and lung CD4 + lymphocytes, is significantly less in the in the LED ⁄ BCG group at the Day 21 time point, but is unimpaired in the BCG ⁄ LED group. Figure 3A shows IL-10 elicited from lung CD4 + T cells from the LED ⁄ BCG and LCD ⁄ BGG groups and reveals no detectable up-regulation of IL-10 production by the LED ⁄ BCG group. There are no differences between the groups, and therefore, no demonstrable shift to a CD4 + lymphocyte Th2 profile over this time frame was evident. Figure 3B reveals IL-10 elicited from the lung CD4 + T cells from the BCG ⁄ LED and BCG ⁄ LCD groups. Similarly to the IFN-c data in Fig. 2 , the BCG ⁄ LED group has higher IL-10 levels than does the BCG ⁄ LCD group at several of the time points. However, despite the increased IL-10 production, IFN ⁄ IL-10 ratios favored a Th1 T-cell bias at all times from both groups, because of the concurrently heightened IFN-c levels from the BCG ⁄ LED group. This is consistent with the higher bacterial clearance in the BCG ⁄ LED group.
PLN Cell IFN-c ELISpot Assay
Murine IFN-c ELISpot assays were performed with PLN cells stimulated with PPD from LED ⁄ BCG and BCG ⁄ LED mice and their respective control diet mice. Figure 4A ,B reveal, in representative ELISpot wells, that the PLN cell production of IFN-c from the LED ⁄ BCG mice was significantly impaired compared with the LCD ⁄ BCG (and Chow ⁄ BCG) control mice. However, IFN-c spot-forming cells in the BCG ⁄ LED mice were not different from the BCG ⁄ LCD (nor the BCG ⁄ Chow) control mice (Fig. 4B) . Removal of the CD8 + T cells by selection from the total PLN cells (CD4   +   CD8 ) group, thereby enriching the population for CD4 + lymphocytes) had no significant influence on the results. Control (unstimulated) wells had a mean of 6 spots. These results confirm that the effect of alcohol consumption on impairing IFN-c production is only evident when alcohol is present at the time of BCG vaccination. When alcohol administration is begun after vaccination, the production of IFN-c from the regional lymph nodes is unimpaired. See Table 1 for group results. (Baldwin et al., 1998; Brooks et al., 2001; Mason et al., 2001) . BCG-induced protection is related to earlier, more robust LALN and lung CD4 + Th1 lymphocyte responses after M. tuberculosis inoculation as compared to unvaccinated mice (Mason et al., 2001) . Here, we report that chronic alcohol consumption can ablate this protection in mice, but importantly, that the timing of the alcohol exposure in relationship to vaccination is critical in determining whether the protection is intact or not. When alcohol consumption is started prior to BCG vaccination, it adversely alters M. tuberculosis growth control, ablating the vaccine protection. If alcohol is begun after BCG vaccination, there is no significant impact on protection. We also demonstrate that locoregional CD4 + lymphocyte production of IFN-c, the Th1 cytokine critical to mycobacterial growth control (Cooper et al., 1993; Flynn et al., 1993) , is differentially affected by the timing of the alcohol consumption in relation to the vaccination. This effect is demonstrable both in the regional PLNs after BCG vaccination, and in the lung after M. tuberculosis challenge of vaccinated mice. Our work is consistent with the primary effect of alcohol occurring at the time of initiation of adaptive immunity at the dendritic cell (DC) ⁄ CD4 + T-cell juncture, potentially adversely affecting both the DC and the CD4 + T cell.
There are limited reports of the effects of alcohol consumption on vaccination. Most have evaluated the response to hepatitis B vaccination as determined by seroconversion, and the reported alcohol effects are varied: most studies report alcohol use as a risk for impaired seroconversion (Hagedorn et al., 2010; Kim et al., 2008; Wang and Lin, 2007) . However, others report either no impairment in vaccine serological response in alcohol-consuming subjects (Kulkarni et al., 2006), or that alcoholics can mount antibody responses to vaccination, but that with continued consumption, responses may not be as durable as in nonconsuming subjects (Nalpas et al., 1993) . In many of these reports, quantitation of alcohol consumption is poorly described, making the studies difficult to compare. Other investigators found decreased lymphocyte proliferation and serological responses to tetanus toxoid vaccination in offspring of nonhuman primate mothers that were fed weekly doses of ethanol while pregnant (Grossman et al., 1993) . Thus, alcohol is capable of altering the development of immunity. Serological responses to vaccination were the primary outcome of these reports, but for M. tuberculosis infection, the T-cell arm of adaptive immunity is most relevant. Studies have shown the impact of alcohol on this arm of the immune system as well. Fan and colleagues (2011) noted reduced proliferation of ethanol-unexposed CD4 + and CD8 + T cells after stimulation by ethanol-exposed, ovalbumin (OVA) peptide-stimulated DCs, which was partially restored by stimulation with a greater amount of peptide. DC antigen capture and processing was intact, but costimulatory molecule upregulation and cytokine production were depressed by ethanol. Gurung and colleagues (2009) reported that CD8 + T cells from ethanol-exposed mice had dampened responses to Listeria monocytogenes peptide epitopes (as compared to CD4 + T cells), including proliferation and cytokine production. Spies and colleagues (2004) evaluated cell-mediated immunity in long-term alcoholics undergoing elective gastrointestinal surgery, and found that alcoholic patients had significantly reduced delayed-type hypersensitivity (DTH) responses to skin testing with a panel of common antigens, as well as reduced Th1:Th2 T-cell ratios and IFN-c:IL-10 ratios (from lipopolysaccharide-stimulated whole blood cells) that failed to increase postoperatively, as occurred in the nonalcoholics. The alcoholics also had significantly higher rates of postoperative infections, especially pneumonia. Thus, alcohol exposure may impair the serological and ⁄ or cellular immune response to antigenic challenge, of which the cellular responses may have significant import for infection with M. tuberculosis.
To further dissect the early effects of alcohol on the inflammatory events at the juncture of innate and adaptive immunity, Heinz and Waltenbaugh (2007) studied the development of adaptive immunity in a murine model of OVA sensitization. Mice that fed an alcohol diet for 11 days had impaired CD4 + T-cell Th1 cytokine production, as well as diminished DTH response to OVA but enhanced Th2 (IL-13) cytokine production (Heinz and Waltenbaugh, 2007) . CD11c + DC profiles were further evaluated in this model, and were found to be the most potent inducers of CD4 + T-cell cytokines, but also to be adversely affected when derived from alcoholconsuming mice. Alcohol-exposed DCs resulted in significantly reduced CD4 + T-cell IFN-c and IL-12, but unimpaired IL-2 production. Other investigators have also described numerous adverse effects of alcohol on DC number and function, including reduced antigen presentation, reduced T-cell stimulation, deranged cytokine production, and decreased ability to polarize Th1 T cells (Edsen-Moore et al., 2008; Lau et al., 2006; Mandrekar et al., 2004; Mikszta et al., 1995; Siggins et al., 2009; Szabo et al., 2004) . Thus, ethanol may lead to protean effects on immune cells, including DCs and T cells. Our work is consistent with many features of the described alterations.
We also noted in mice in which BCG protection remains intact, lung CD4 + T-cell production of IFN-c and IL-10 is of greater magnitude than that of the nonalcohol-consuming control mice. There are numerous reports in the literature of acute alcohol consumption down-regulating proinflammatory cytokines, such as tumor necrosis factor (TNF), IL-1, and IL-6 (D' Souza et al., 1989; Lin et al., 1998; Nelson et al., 1989a,b; Stoltz et al., 2000; Szabo et al., 1995) , but also that subacute or chronic consumption may up-regulate inflammatory cytokines, including TNF (Enomoto et al., 2001; Kamimura and Tsukamoto, 1995) , IL-1 and transforming growth factor-beta (Martinez et al., 1992; Spies et al., 2004) , IL-6 (Hong et al., 2002) , IL-10, IL-12, and IFN-c (Plackett et al., 2005; Szabo, 1998; Zisman et al., 1998) . The etiology of inflammatory cytokine up-regulation is not completely clear, but several mechanisms have been postulated. Chronic alcohol may increase the permeability of the gut and allow endotoxin to breach the intestinal barrier, gaining access to the portal circulation (Mason et al., 1998) ; alcohol may enhance Kupffer cell expression of CD14 and heightened TNF production early after alcohol begins (Enomoto et al., 2001 ); uptake and degradation of plasma cytokines may be variably affected by alcohol and may influence cytokine clearance rates (Deaciuc et al., 1996) ; and ⁄ or dysregulation of plasma glucocorticoid levels by alcohol may result in an imbalance of regulatory and proinflammatory cytokines, favoring the proinflammatory cascade (Barber et al., 1993; Sipp et al., 1993; Waltman et al., 1993) .
In this work, we used BCG vaccination as a model for studying the impact of alcohol on the development of adaptive immunity because BCG is currently the sole vaccine for M. tuberculosis and has been used for decades in humans, especially in developing countries. Given at a very young age, it protects neonates and children against tuberculous meningitis and other extrapulmonary or disseminated forms of tuberculosis, but is not effective in adolescents and adults for prevention of initial infection or reactivation disease (Antas and Castello-Branco, 2008). BCG being a live vaccine should not be administered to immunocompromised hosts, in particular those infected with HIV. Thus, with the burgeoning global burden of M. tuberculosis infection, the specter of highly drug-resistant strains emerging, in addition to the problems with BCG efficacy, the race is on for a more effective vaccine. The ideal vaccine will be effective in preexposure states to prevent infection, and also in the postexposure situation (latent infection) to prevent reactivation. Some of the vaccine candidates currently in early trials are based on live BCG or M. tuberculosis (though these strains are attenuated and modified for greater efficacy) and are being administered to adults in ongoing clinical trials (Kaufmann et al., 2010) . Most of the trials are being conducted in the developing world, which has the highest rates of endemic tuberculosis. These areas are fraught with significant socioeconomic problems, for example, poverty, homelessness, malnutrition, mental illness, and often substance abuse, including alcohol. As previously mentioned, alcohol consumption has been identified as a risk factor for tuberculosis infection and active tuberculosis, as well as for greater morbidity and mortality from tuberculosis. Our results reported here shed light on the impact of alcohol on BCG vaccination efficacy in mice, especially in regard to the relative timing of alcohol consumption and BCG administration. As new vaccine candidates are being evaluated in clinical trials in adolescents and adults, our results provide the basis for consideration of current alcohol use by vaccine recipients as a potential confounding variable in vaccine efficacy.
In summary, we have demonstrated for the first time that the impact of the differential timing of alcohol consumption in relation to BCG vaccination on the efficacy of protection against a subsequent challenge with the pathogen M. tuberculosis in mice. Vaccination while the host is actively consuming alcohol leads to failure of vaccine protection in our model, but vaccination prior to initiation of alcohol leads to intact protection. Our findings directly correlate with the production of IFN-c by locoregional CD4 + T cells in M. tuberculosischallenged mice, as well as by the PLN cells after BCG vaccination alone. Thus, alcohol disrupts the development of adaptive immunity to BCG, but only if alcohol is being actively consumed at the time of the vaccination. Our findings may have relevance to efficacy of future tuberculosis vaccines, and possibly more broadly, to other vaccines as well.
